FindTrial
Sign In

Gestational Diabetes Study

Markers For Early Risk-Stratification Of Gestational Diabetes (MERGD)�: A Prospective Cohort Study - MERGD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013946
Enrollment
1500
Registered
2018-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pregnant Women

Interventions

None listed

Sponsors

Lata Medical Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. If the candidate woman has come to antenatal care before 20 weeks of gestation 2. Those who have consented

Exclusion criteria

Exclusion criteria: 1. If the candidate woman has come to antenatal care after 20 weeks of gestation 2. Those who have not consented

Design outcomes

Primary

MeasureTime frame
Quantify the burden of GD in central IndiaTimepoint: At the time of delivery—

Secondary

MeasureTime frame
biomarker-based incremental prediction of maternal and fetal outcomes over and beyond that based on clinical risk factors.Timepoint: After 1 year—

Countries

India

Contacts

Public ContactArchana Patel

Trustee, Lata Medical Research Foundation

manjuhemant@gmail.com9823350019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026